MedPath

Ivermectin

Ivermectin Tablets USP, 3mg (IVERMECTIN)

Approved
Approval ID

847a1dd7-d65b-4a0e-a67d-d90392059dac

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 20, 2023

Manufacturers
FDA

Edenbridge Pharmaceuticals LLC.

DUNS: 948715060

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ivermectin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42799-806
Application NumberANDA204154
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ivermectin
Product Specifications
Route of AdministrationORAL
Effective DateNovember 20, 2023
FDA Product Classification

INGREDIENTS (6)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
IVERMECTINActive
Quantity: 3 mg in 1 1
Code: 8883YP2R6D
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ivermectin - FDA Drug Approval Details